Review of allergic contact dermatitis: Scratching the surface

Ceylon cinnamon and clove essential oils as promising free radical scavengers for skin care products

Due to adverse effects of free radicals on human skin and increasing consumer demand for natural ingredients, essential oils from basil, Ceylon cinnamon bark, clove, juniper, lavender, oregano, rosemary, tea tree, thyme, and ylang-ylang were assessed for their antiradical activity. The oils were evaluated in the concentration range of 5—0.1 mg·mL−1, in which the three reference synthetic antioxidants are most often added to mass-produced cosmetics. Among all examined samples, C. cinnamon oil at a concentration of 5 mg·mL−1 showed the strongest DPPH radical scavenging activity (0.41 mg·mL−1 IC50), followed by clove oil, BHA, α-tocopherol, and BHT (0.82, 0.84, 0.88 and 0.93 mg·mL−1 IC50), respectively. At the same concentration, the reduction power of C. cinnamon oil was higher (1.64 mg·mL−1 Trolox Eq.) than that of α-tocopherol and BHT (1.42 and 0.80 mmol·L−1 Trolox Eq., respectively) but lower than that of BHA (1.81 mmol·L–1 Trolox Eq.). Antiradical activity of the other eight essential oils was low or negligible. C. cinnamon oil and clove oil are promising antiradical agents for skin care but according to our GC-MS analysis, these oils contain 0.29 % of cinnamaldehyde, 0.03 % of linalool, 0.02 % of D-limonene, and 0.02 % of eugenol or 0.41 % of eugenol and 0.002 % of linalool, respectively, which are monitored contact allergens in cosmetics. Such a product is not be suitable for consumers allergic to these substances but for the vast majority of consumers it does not pose a risk in terms of allergic manifestations.

The Eastern European experience on occupational skin diseases. Make underreporting an issue?

BACKGROUND

While legislation in most of the Eastern European countries is nowadays widely harmonized with the legal safety and health provisions of Western countries, there is still a sustained resistance to the notification of occupational skin diseases (OSD).

OBJECTIVE

The aim of the study was to identify the main barriers in notification and recognition of OSD in 22 Eastern European countries.

METHODS

An online survey was administered to key persons in the field of occupational safety and health in 22 Eastern European countries. Multiple variables of the notification system were studied, including clinical, organizational and educational issues.

RESULTS

The main causes of underreporting OSD are ineffective enforcement of occupational safety and health legislation, contractual relationship employer-employee, long duration of the notifying process, restrictions of the notification systems in terms of who is entitled to notify an OSD, ineffective regulations in regards to the pre-employment and periodical medical examination, ineffective compensation schemes, restraints and hesitations, mainly from the doctors, inappropriate mentalities - fear of losing the jobs, fining of the employers by the authorities, stigmatization of the workers with OSD, additional costs for employers, stakeholders' lack of interest in notifying, lack of guidelines and protocols and lack of preventive programmes.

CONCLUSIONS

The most valuable method for a proper recognition of OSD is to increase the awareness of physicians involved in the management of OSD (occupational physicians, GPs, dermatologists), as well as employers and workers. There is an urgent need to improve national legislation, to develop and promote adequate preventive programmes, emphasizing ethical, legal, economical and psychological aspects in order to achieve an increased recognition and a real reporting of OSD, and to enforce an international action plan for Eastern Europe in order to improve the notification of OSD.

P2X7 receptor in skin biology and diseases

The P2X7 receptor is a trimeric ligand-gated cation channel present on immune and other cells. Activation of this receptor by its natural ligand extracellular adenosine triphosphate results in a variety of downstream responses, including the release of pro-inflammatory mediators and cell death. In normal skin, P2X7 is present on keratinocytes, Langerhans cells and fibroblasts, while the presence of this receptor on other cutaneous cells is mainly inferred from studies of equivalent cell types present in other tissues. Mast cells in normal skin however express negligible amounts of P2X7, which can be upregulated in cutaneous disease. This review discusses the potential significance of P2X7 in skin biology, and the role of this receptor in inflammatory skin disorders such as irritant and chronic dermatitis, psoriasis, graft-versus-host disease, as well is in wound healing, transplantation and skin cancer.